glp-1 birth defects Taking GLP-1s during the first trimester of pregnancy does not appear to substantially increase the risk of adverse outcomes GLP-1 use during early pregnancy

A 2023 randomized controlled trial published in the BMJ (N=410) found that spironolactone 50 to 100 mg/day produced a significantly greater reduction in acne lesion count versus placebo at 24 weeks, with a mean difference of 12.0 fewer inflammatory lesions (95% CI 7.6 to 16.4, P 90% (albumin) | Low

Those with severe deficiency might need up to 1000 mcg daily

Inside the Viral Tanning Peptide That Accidentally Created Vyleesis FDA-Approved Low Sex Drive Drug Unverified sunless tanning injections are exploding across social media, but their real scientific legacy isnt a dark complexion

In this months newsletter, Clinical Research Associate Joe Bonner, PhD will briefly review how this can happen and the importance of tracking skeletal muscle mass during weight loss

This promotes a feeling of fullness and may help with weight management